RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems

July 15, 2026 updated by: Duke University

RAndomized Cluster Evaluation of Cardiac ARrest Systems

RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of approximately 20,000 patients with cardiac arrest over a 4-year intervention period. County "clusters" will be randomized in a 1:1 ratio to intervention versus usual care. The trial duration is 7 years, which includes a 6-month start-up (including recruitment and randomization) period, a 12-month intervention training phase, a 4-year intervention period, a 12-month follow-up for to assess quality of life in survivors of OHCA, and a 6-month close-out and data analysis period.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Duke

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • OHCA of non-traumatic etiology
  • Patients who are pulseless on arrival of a first responder; or patients who become pulseless in the presence of a first responder; OR patients who have a pulse on arrival of EMS, where a successful defibrillation was previously administered by a bystander or first responder.

Exclusion Criteria:

  • Untreated cardiac arrests, including arrests in which resuscitation efforts are not initiated or are terminated immediately upon arrival of EMS because the patient is not a viable candidate for resuscitation due to:

    1. injuries incompatible with life,
    2. the presence of rigor mortis or lividity,
    3. signs of decomposition, or
    4. the presence of a valid DNR.
  • Private EMS transport that did not involve 911 dispatch (example: interfacility transport between nursing home and hospital).
  • Arrest of clear and obvious traumatic etiology
  • Bystander suspected cardiac arrest, where ROSC was achieved without the need for defibrillation or first responder CPR

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention (Enhanced Standard of Care)
Mass community CPR/AED training, optimize 911 medical dispatch, improve first responder performance
EMS first responders will recognize cardiac arrest and respond immediately, increasing time to dispatch
911 operators will be able to describe how to administer CPR over the phone.
Training of lay people regarding CPR and AED use.
First responders will recognize where AEDs are located and use them appropriately
No Intervention: Control (Standard of Care)
Usual care, continuing standard quality improvement effort

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival with good neurologic outcomes as measured by a CPC score of 1 or 2 at discharge
Time Frame: up to 12months
Cerebral Performance Category (CPC)
up to 12months

Secondary Outcome Measures

Outcome Measure
Time Frame
Percent of patients who receive CPR from a bystander as measured by EMS report
Time Frame: Baseline
Baseline
Rate of Defibrillation before paramedics arrive as measured by bystander interview
Time Frame: Baseline
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent of cardiac arrest patients whose cardiac arrests are recognized by 911-dispatcher through telephone call
Time Frame: Follow-up, up to 4 years
Follow-up, up to 4 years
Percent of cardiac arrest patients with responders who receive CPR instructions by 911-dispatcher through telephone call
Time Frame: Follow-up, up to 4 years
Follow-up, up to 4 years
Survival rate as measured by medical record abstraction
Time Frame: Follow-up, up to 4 years
Follow-up, up to 4 years
Change in Neurologic disability as measured by Modified Rankin Score
Time Frame: 3 months, 12 months
The Modified Rankin Score is a 6 point likert scale, with 0 being "No symptoms" and 6 being "Dead"
3 months, 12 months
Change in Quality of life as measured by the SF-36
Time Frame: 3 months, 12 months
The SF-36 is Is a health-related quality-of-life questionnaire consisting of thirty six questions that measure eight health domains to assess physical and mental health. Physical health-related domains include General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP).
3 months, 12 months
Change in Quality of life as measured by the EQ-5D-5L
Time Frame: 3 months, 12 months
The EQ-5D-5L is Quality of Life instrument measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
3 months, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Christopher Granger, MD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

December 3, 2020

First Submitted That Met QC Criteria

December 3, 2020

First Posted (Actual)

December 9, 2020

Study Record Updates

Last Update Posted (Actual)

July 16, 2026

Last Update Submitted That Met QC Criteria

July 15, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe